ABCC1 and colitis: ABCC1 has been implicated as a protectant against methotrexate’s toxicity in the intestine after an ABCC1−/− mouse model of colitis found that the disease was associated with higher mortality and severe epithelia damage (ten Hove et al., 2002; Kato et al., 2009; Cole, 2014b).